ASPECCT_3A | R Documentation |
Kaplan-Meier digitized data from ASPECCT, figure 3A (PMID 24739896). A reported sample size of 1,010 for a primary endpoint of OS in colorectal cancer.
ASPECCT_3A
A data frame of 999 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (cetuximab, panitumumab) | |
Price TJ, Peeters M, Kim TW, et al. Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study. Lancet Oncol 2014; 15: 569–79.
summary(ASPECCT_3A)
kmplot(ASPECCT_3A)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.